Paper526397
Pharmacokinetics and pharmacodynamic studies of labetalol in hypertensive subjects.
McNeil JJ and 3 others. Br J Clin Pharmacol, 1979. Cited by 33 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Pharmacokinetics and pharmacodynamic studies of labetalol in hypertensive subjects. Papers, record 526397. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/526397
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ethanolamines | Major topic |
| Hypertension | Major topic |
| Labetalol | Major topic |
| Administration, Oral | |
| Adult | |
| Aged | |
| Blood Pressure | |
| Female | |
| Half-Life | |
| Humans | |
| Injections, Intravenous | |
| Kinetics | |
| Male | |
| Middle Aged | |
| Time Factors |
Source PubMed
References8
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14,010 | Relationship between plasma concentrations and pharmacological effects of labetalol. | Eur J Clin Pharmacol | 1977 | https://conductscience.org/library/papers/14010 | PubMed |
| 2 | 10,951 | Combined alpha- and beta-adrenoreceptors blockade with oral labetalol in hypertensive patients with reference to haemodynamic effects at rest and during exercise. | Br J Clin Pharmacol | 1976 | https://conductscience.org/library/papers/10951 | PubMed |
| 3 | 285,681 | Labetalol: bioavailability, drug plasma levels, plasma renin and catecholamines in acute and chronic treatment of resistant hypertension. | Aust N Z J Med | 1978 | https://conductscience.org/library/papers/285681 | PubMed |
| 4 | 5,411,325 | Assessment of pharmacokinetic constants from postinfusion blood curves obtained after I.V. infusion. | J Pharm Sci | 1970 | https://conductscience.org/library/papers/5411325 | PubMed |
| 5 | 990,152 | Metabolism of labetalol by animals and man. | Br J Clin Pharmacol | 1976 | https://conductscience.org/library/papers/990152 | PubMed |
| 6 | 4,404,413 | Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors. | Br J Pharmacol | 1972 | https://conductscience.org/library/papers/4404413 | PubMed |
| 7 | 4,148,916 | Clinical investigation of an antagonist at alpha- and beta-adrenoceptors-AH5158A. | Br J Pharmacol | 1972 | https://conductscience.org/library/papers/4148916 | PubMed |
| 8 | 709,214 | Decreased first-pass metabolism of labetalol in chronic liver disease. | Br Med J | 1978 | https://conductscience.org/library/papers/709214 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38,973,651 | Labetalol Dosing in Pregnancy: PBPK/PD and CYP2C19 Polymorphisms. | J Clin Pharmacol | 2024 | https://conductscience.org/library/papers/38973651 | PubMed |
| 37,142,805 | Physiologically Based Pharmacokinetic Modeling for Multiple Oral Administration Labetalol in Pregnant Women. | Pharm Res | 2023 | https://conductscience.org/library/papers/37142805 | PubMed |
| 35,000,148 | Pseudopheochromocytoma: an Uncommon Cause of Severe Hypertension. | Curr Cardiol Rep | 2022 | https://conductscience.org/library/papers/35000148 | PubMed |
| 34,112,223 | Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup. | Crit Care | 2021 | https://conductscience.org/library/papers/34112223 | PubMed |
| 31,875,885 | Measuring effects of medication adherence on time-varying health outcomes using Bayesian dynamic linear models. | Biostatistics | 2021 | https://conductscience.org/library/papers/31875885 | PubMed |
| 31,655,774 | Pseudopheochromocytoma. | Endocrinol Metab Clin North Am | 2019 | https://conductscience.org/library/papers/31655774 | PubMed |
| 27,738,531 | Pseudopheochromocytoma Associated with Domestic Assault. | Case Rep Cardiol | 2016 | https://conductscience.org/library/papers/27738531 | PubMed |
| 26,186,619 | Labetalol Prevents Intestinal Dysfunction Induced by Traumatic Brain Injury. | PLoS One | 2015 | https://conductscience.org/library/papers/26186619 | PubMed |
| 23,327,720 | Comparison of the permeability of metoprolol and labetalol in rat, mouse, and Caco-2 cells: use as a reference standard for BCS classification. | Mol Pharm | 2013 | https://conductscience.org/library/papers/23327720 | PubMed |
| 21,272,200 | Drug therapy for resistant hypertension: simplifying the approach. | J Clin Hypertens (Greenwich) | 2011 | https://conductscience.org/library/papers/21272200 | PubMed |
| 18,367,021 | Severe paroxysmal hypertension (pseudopheochromocytoma). | Curr Hypertens Rep | 2008 | https://conductscience.org/library/papers/18367021 | PubMed |
| 17,786,066 | Combined alpha/beta-blockade: an underused approach to the treatment of resistant hypertension. | J Clin Hypertens (Greenwich) | 2007 | https://conductscience.org/library/papers/17786066 | PubMed |
| 7,295,464 | Circulatory and metabolic effects of a combined alpha- and beta-adrenoceptor blocker (labetalol) in hypertension of pregnancy. | Br J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7295464 | PubMed |
| 7,104,187 | Bioavailability of labetalol increases with age. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7104187 | PubMed |
| 7,104,169 | The influence of food on the oral and intravenous pharmacokinetics of a high clearance drug: a study with labetalol. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7104169 | PubMed |
| 7,093,102 | Labetalol steady-state pharmacokinetics in hypertensive patients. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7093102 | PubMed |
| 6,370,541 | Clinical pharmacokinetics of labetalol. | Clin Pharmacokinet | 1984 | https://conductscience.org/library/papers/6370541 | PubMed |
| 6,151,889 | Pharmacology of combined alpha-beta-blockade. I. | Drugs | 1984 | https://conductscience.org/library/papers/6151889 | PubMed |
| 2,663,413 | Labetalol. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in hypertension and ischaemic heart disease. | Drugs | 1989 | https://conductscience.org/library/papers/2663413 | PubMed |
| 1,884,570 | Clinical pharmacokinetics and kinetic-dynamic relationships of dilevalol and labetalol. | Clin Pharmacokinet | 1991 | https://conductscience.org/library/papers/1884570 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/526397
GET https://conductscience.org/api/papers/v1/526397/authors